ID GUC2F_HUMAN Reviewed; 1108 AA. AC P51841; Q9UJF1; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 02-NOV-2010, sequence version 2. DT 12-AUG-2020, entry version 194. DE RecName: Full=Retinal guanylyl cyclase 2; DE Short=RETGC-2 {ECO:0000303|PubMed:7777544}; DE EC=4.6.1.2 {ECO:0000269|PubMed:7777544}; DE AltName: Full=Guanylate cyclase 2F, retinal {ECO:0000312|HGNC:HGNC:4691}; DE AltName: Full=Guanylate cyclase F; DE Short=GC-F; DE AltName: Full=Rod outer segment membrane guanylate cyclase 2; DE Short=ROS-GC2; DE Flags: Precursor; GN Name=GUCY2F; Synonyms=GUC2F, RETGC2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLN-296, TISSUE SPECIFICITY, ACTIVITY RP REGULATION, AND CATALYTIC ACTIVITY. RC TISSUE=Retina; RX PubMed=7777544; DOI=10.1073/pnas.92.12.5535; RA Lowe D.G., Dizhoor A.M., Liu K., Gu Q., Spencer M., Laura R., Lu L., RA Hurley J.B.; RT "Cloning and expression of a second photoreceptor-specific membrane retina RT guanylyl cyclase (RetGC), RetGC-2."; RL Proc. Natl. Acad. Sci. U.S.A. 92:5535-5539(1995). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15772651; DOI=10.1038/nature03440; RA Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., RA Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., RA Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C., RA Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., RA Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., RA Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., RA Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., RA Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., RA Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., RA Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., RA Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., RA Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., RA Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., RA Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., RA Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., RA Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., RA Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., RA Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., RA Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., RA Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., RA Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., RA Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., RA Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., RA Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., RA Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., RA Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., RA Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., RA Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., RA Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., RA Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., RA McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., RA Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., RA Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., RA Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., RA Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., RA Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., RA Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., RA Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., RA Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., RA Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., RA d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., RA Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., RA Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., RA Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., RA Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., RA Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., RA Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., RA Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., RA Rogers J., Bentley D.R.; RT "The DNA sequence of the human X chromosome."; RL Nature 434:325-337(2005). RN [3] RP VARIANT [LARGE SCALE ANALYSIS] PRO-10. RX PubMed=16959974; DOI=10.1126/science.1133427; RA Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., RA Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., RA Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., RA Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., RA Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., RA Velculescu V.E.; RT "The consensus coding sequences of human breast and colorectal cancers."; RL Science 314:268-274(2006). RN [4] RP VARIANTS [LARGE SCALE ANALYSIS] CYS-40; ASN-160; TRP-230; PRO-284; GLN-305; RP CYS-308; HIS-380; ARG-434; ASP-568; GLN-628; LEU-677; LYS-794; VAL-1010; RP ARG-1052 AND ASP-1055. RX PubMed=17344846; DOI=10.1038/nature05610; RA Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., RA Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., RA Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., RA Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., RA Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., RA Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., RA Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., RA Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., RA Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., RA Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., RA Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., RA Futreal P.A., Stratton M.R.; RT "Patterns of somatic mutation in human cancer genomes."; RL Nature 446:153-158(2007). RN [5] RP VARIANT ASP-872. RX PubMed=23033978; DOI=10.1056/nejmoa1206524; RA de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G., RA Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C., RA del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G., RA Veltman J.A., Vissers L.E.; RT "Diagnostic exome sequencing in persons with severe intellectual RT disability."; RL N. Engl. J. Med. 367:1921-1929(2012). RN [6] RP ACTIVITY REGULATION. RX PubMed=29515371; DOI=10.3389/fnmol.2018.00052; RA Wimberg H., Janssen-Bienhold U., Koch K.W.; RT "Control of the Nucleotide Cycle in Photoreceptor Cell Extracts by Retinal RT Degeneration Protein 3."; RL Front. Mol. Neurosci. 11:52-52(2018). CC -!- FUNCTION: Responsible for the synthesis of cyclic GMP (cGMP) in rods CC and cones of photoreceptors (PubMed:7777544). Plays an essential role CC in phototransduction, by mediating cGMP replenishment (By similarity). CC May also participate in the trafficking of membrane-asociated proteins CC to the photoreceptor outer segment membrane (By similarity). CC {ECO:0000250|UniProtKB:Q5SDA5, ECO:0000269|PubMed:7777544}. CC -!- CATALYTIC ACTIVITY: CC Reaction=GTP = 3',5'-cyclic GMP + diphosphate; Xref=Rhea:RHEA:13665, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:37565, ChEBI:CHEBI:57746; EC=4.6.1.2; CC Evidence={ECO:0000269|PubMed:7777544}; CC -!- ACTIVITY REGULATION: Activated by GUCA1B when free calcium ions CC concentration is low, and inhibited by GUCA1B when free calcium ions CC concentration is high (PubMed:15772651). Inhibited by RD3 CC (PubMed:29515371). {ECO:0000269|PubMed:15772651, CC ECO:0000269|PubMed:29515371}. CC -!- SUBUNIT: Homodimer (By similarity). Interacts with RD3; promotes the CC exit of GUCY2F from the endoplasmic reticulum and its trafficking to CC the photoreceptor outer segments (By similarity). CC {ECO:0000250|UniProtKB:P51842, ECO:0000250|UniProtKB:Q5SDA5}. CC -!- SUBCELLULAR LOCATION: Photoreceptor outer segment membrane CC {ECO:0000250|UniProtKB:O02740}; Single-pass type I membrane protein CC {ECO:0000255}. CC -!- TISSUE SPECIFICITY: Retina. Localized exclusively in the outer nuclear CC layer and inner segments of the rod and cone photoreceptor cells. CC {ECO:0000269|PubMed:7777544}. CC -!- DOMAIN: The protein kinase domain is predicted to be catalytically CC inactive. CC -!- PTM: There are 9 conserved cysteine residues in sensory guanylate CC cyclases, 6 in the extracellular domain, which may be involved in CC intra- or interchain disulfide bonds. CC -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase CC family. {ECO:0000255|PROSITE-ProRule:PRU00099}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L37378; AAA74451.1; -; mRNA. DR EMBL; AL031387; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS14545.1; -. DR PIR; I59385; I59385. DR RefSeq; NP_001513.2; NM_001522.2. DR SMR; P51841; -. DR BioGRID; 109241; 2. DR IntAct; P51841; 2. DR MINT; P51841; -. DR STRING; 9606.ENSP00000218006; -. DR iPTMnet; P51841; -. DR PhosphoSitePlus; P51841; -. DR BioMuta; GUCY2F; -. DR DMDM; 311033391; -. DR jPOST; P51841; -. DR MassIVE; P51841; -. DR MaxQB; P51841; -. DR PaxDb; P51841; -. DR PeptideAtlas; P51841; -. DR PRIDE; P51841; -. DR ProteomicsDB; 56431; -. DR Antibodypedia; 29460; 98 antibodies. DR DNASU; 2986; -. DR Ensembl; ENST00000218006; ENSP00000218006; ENSG00000101890. DR GeneID; 2986; -. DR KEGG; hsa:2986; -. DR UCSC; uc065aqx.1; human. DR CTD; 2986; -. DR DisGeNET; 2986; -. DR EuPathDB; HostDB:ENSG00000101890.4; -. DR GeneCards; GUCY2F; -. DR HGNC; HGNC:4691; GUCY2F. DR HPA; ENSG00000101890; Tissue enriched (retina). DR MIM; 300041; gene. DR neXtProt; NX_P51841; -. DR OpenTargets; ENSG00000101890; -. DR PharmGKB; PA29071; -. DR eggNOG; KOG1023; Eukaryota. DR GeneTree; ENSGT00940000162146; -. DR HOGENOM; CLU_001072_1_0_1; -. DR InParanoid; P51841; -. DR KO; K12322; -. DR OMA; ICRGGID; -. DR OrthoDB; 229634at2759; -. DR PhylomeDB; P51841; -. DR TreeFam; TF106338; -. DR BRENDA; 4.6.1.2; 2681. DR PathwayCommons; P51841; -. DR Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade. DR BioGRID-ORCS; 2986; 3 hits in 522 CRISPR screens. DR ChiTaRS; GUCY2F; human. DR GenomeRNAi; 2986; -. DR Pharos; P51841; Tbio. DR PRO; PR:P51841; -. DR Proteomes; UP000005640; Chromosome X. DR RNAct; P51841; protein. DR Bgee; ENSG00000101890; Expressed in right uterine tube and 9 other tissues. DR Genevisible; P51841; HS. DR GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc. DR GO; GO:0005640; C:nuclear outer membrane; TAS:ProtInc. DR GO; GO:0097381; C:photoreceptor disc membrane; TAS:Reactome. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0120200; C:rod photoreceptor outer segment; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:InterPro. DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW. DR GO; GO:0004383; F:guanylate cyclase activity; IBA:GO_Central. DR GO; GO:0042802; F:identical protein binding; IEA:Ensembl. DR GO; GO:0016941; F:natriuretic peptide receptor activity; IBA:GO_Central. DR GO; GO:0017046; F:peptide hormone binding; IBA:GO_Central. DR GO; GO:0001653; F:peptide receptor activity; IBA:GO_Central. DR GO; GO:0004672; F:protein kinase activity; IEA:InterPro. DR GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl. DR GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc. DR GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central. DR GO; GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl. DR GO; GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl. DR GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IBA:GO_Central. DR GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome. DR GO; GO:0007165; P:signal transduction; IBA:GO_Central. DR GO; GO:0007601; P:visual perception; TAS:ProtInc. DR Gene3D; 3.30.70.1230; -; 1. DR InterPro; IPR001054; A/G_cyclase. DR InterPro; IPR018297; A/G_cyclase_CS. DR InterPro; IPR001828; ANF_lig-bd_rcpt. DR InterPro; IPR033484; GUCY2F. DR InterPro; IPR011645; HNOB_dom_associated. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR029787; Nucleotide_cyclase. DR InterPro; IPR028082; Peripla_BP_I. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom. DR PANTHER; PTHR11920:SF349; PTHR11920:SF349; 1. DR Pfam; PF01094; ANF_receptor; 1. DR Pfam; PF00211; Guanylate_cyc; 1. DR Pfam; PF07701; HNOBA; 1. DR Pfam; PF07714; Pkinase_Tyr; 1. DR PRINTS; PR00109; TYRKINASE. DR SMART; SM00044; CYCc; 1. DR SUPFAM; SSF53822; SSF53822; 1. DR SUPFAM; SSF55073; SSF55073; 1. DR SUPFAM; SSF56112; SSF56112; 1. DR PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1. DR PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. PE 1: Evidence at protein level; KW Cell projection; cGMP biosynthesis; Disulfide bond; GTP-binding; Lyase; KW Membrane; Nucleotide-binding; Polymorphism; Reference proteome; KW Sensory transduction; Signal; Transmembrane; Transmembrane helix; Vision. FT SIGNAL 1..50 FT /evidence="ECO:0000255" FT CHAIN 51..1108 FT /note="Retinal guanylyl cyclase 2" FT /id="PRO_0000012386" FT TOPO_DOM 51..467 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 468..490 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 491..1108 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 532..812 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT DOMAIN 884..1014 FT /note="Guanylate cyclase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00099" FT DISULFID 104..132 FT /evidence="ECO:0000250" FT DISULFID 452 FT /note="Interchain" FT /evidence="ECO:0000250" FT DISULFID 460 FT /note="Interchain" FT /evidence="ECO:0000250" FT VARIANT 10 FT /note="R -> P (in a breast cancer sample; somatic mutation; FT dbSNP:rs755991142)" FT /evidence="ECO:0000269|PubMed:16959974" FT /id="VAR_036419" FT VARIANT 40 FT /note="S -> C (in dbSNP:rs34228145)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042233" FT VARIANT 160 FT /note="I -> N (in dbSNP:rs33971675)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042234" FT VARIANT 230 FT /note="R -> W (in dbSNP:rs33973457)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042235" FT VARIANT 284 FT /note="L -> P (in dbSNP:rs12008095)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_009136" FT VARIANT 296 FT /note="R -> Q (in dbSNP:rs502209)" FT /evidence="ECO:0000269|PubMed:7777544" FT /id="VAR_009137" FT VARIANT 305 FT /note="R -> Q (in dbSNP:rs55966326)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042236" FT VARIANT 308 FT /note="Y -> C (in dbSNP:rs16985750)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_030633" FT VARIANT 380 FT /note="Q -> H (in dbSNP:rs2272925)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_030634" FT VARIANT 434 FT /note="G -> R (in dbSNP:rs56293008)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042237" FT VARIANT 568 FT /note="G -> D (in a glioblastoma multiforme sample; somatic FT mutation; dbSNP:rs779221554)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042238" FT VARIANT 628 FT /note="R -> Q (in dbSNP:rs7883913)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_030635" FT VARIANT 677 FT /note="V -> L (in dbSNP:rs35474112)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042239" FT VARIANT 794 FT /note="E -> K (in dbSNP:rs35726803)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042240" FT VARIANT 872 FT /note="G -> D (in dbSNP:rs148663380)" FT /evidence="ECO:0000269|PubMed:23033978" FT /id="VAR_069424" FT VARIANT 1010 FT /note="A -> V (in dbSNP:rs55735218)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042241" FT VARIANT 1052 FT /note="K -> R (in a lung adenocarcinoma sample; somatic FT mutation)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042242" FT VARIANT 1055 FT /note="E -> D (in a lung squamous cell carcinoma sample; FT somatic mutation)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_042243" SQ SEQUENCE 1108 AA; 124850 MW; B047BBF1A3C009F9 CRC64; MFLGLGRFSR LVLWFAAFRK LLGHHGLASA KFLWCLCLLS VMSLPQQVWT LPYKIGVVGP WACDSLFSKA LPEVAARLAI ERINRDPSFD LSYSFEYVIL NEDCQTSRAL SSFISHHQMA SGFIGPTNPG YCEAASLLGN SWDKGIFSWA CVNYELDNKI SYPTFSRTLP SPIRVLVTVM KYFQWAHAGV ISSDEDIWVH TANRVASALR SHGLPVGVVL TTGQDSQSMR KALQRIHQAD RIRIIIMCMH SALIGGETQM HLLECAHDLK MTDGTYVFVP YDALLYSLPY KHTPYRVLRN NPKLREAYDA VLTITVESQE KTFYQAFTEA AARGEIPEKL EFDQVSPLFG TIYNSIYFIA QAMNNAMKEN GQAGAASLVQ HSRNMQFHGF NQLMRTDSNG NGISEYVILD TNLKEWELHS TYTVDMEMEL LRFGGTPIHF PGGRPPRADA KCWFAEGKIC HGGIDPAFAM MVCLTLLIAL LSINGFAYFI RRRINKIQLI KGPNRILLTL EDVTFINPHF GSKRGSRASV SFQITSEVQS GRSPRLSFSS GSLTPATYEN SNIAIYEGDW VWLKKFSLGD FGDLKSIKSR ASDVFEMMKD LRHENINPLL GFFYDSGMFA IVTEFCSRGS LEDILTNQDV KLDWMFKSSL LLDLIKGMKY LHHREFVHGR LKSRNCVVDG RFVLKVTDYG FNDILEMLRL SEEESSMEEL LWTAPELLRA PRGSRLGSFA GDVYSFAIIM QEVMVRGTPF CMMDLPAQEI INRLKKPPPV YRPVVPPEHA PPECLQLMKQ CWAEAAEQRP TFDEIFNQFK TFNKGKKTNI IDSMLRMLEQ YSSNLEDLIR ERTEELEIEK QKTEKLLTQM LPPSVAESLK KGCTVEPEGF DLVTLYFSDI VGFTTISAMS EPIEVVDLLN DLYTLFDAII GSHDVYKVET IGDAYMVASG LPKRNGSRHA AEIANMSLDI LSSVGTFKMR HMPEVPVRIR IGLHSGPVVA GVVGLTMPRY CLFGDTVNTA SRMESTGLPY RIHVSLSTVT ILQNLSEGYE VELRGRTELK GKGTEETFWL IGKKGFMKPL PVPPPVDKDG QVGHGLQPVE IAAFQRRKAE RQLVRNKP //